Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/19/18 → 6/19/21 |
Funding
- Quintiles, Inc. (Agmt 06/19/18 // Agmt 06/19/18)
- Takeda Development Center Americas, Inc. (Agmt 06/19/18 // Agmt 06/19/18)
Vedolizumab-4014: A Phase 4, Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment Outcomes in Nonresponders With Moderately to Severely Active Ulcerative Colitis
Project: Research project